BB BIOTECH AG - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2018. The put-call ratio across all filers is 3.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
BB BIOTECH AG ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q1 2019$141,447,000
-9.4%
3,522,964
+3.8%
3.56%
-28.9%
Q4 2018$156,076,000
+7.1%
3,392,964
+3.4%
5.00%
+29.7%
Q3 2018$145,665,000
+16.8%
3,282,964
+3.1%
3.86%
+7.0%
Q2 2018$124,740,000
-28.5%
3,182,964
+31.9%
3.60%
-25.3%
Q1 2018$174,530,000
+12.2%
2,412,964
+2.1%
4.82%
+10.1%
Q4 2017$155,578,000
+48.0%
2,362,964
+12.6%
4.38%
+50.5%
Q3 2017$105,150,000
+50.1%
2,097,964
+38.6%
2.91%
+36.0%
Q2 2017$70,047,000
+40.8%
1,513,542
+7.5%
2.14%
+31.6%
Q1 2017$49,736,000
+203.6%
1,408,542
+7.6%
1.63%
+168.0%
Q4 2016$16,383,000
-9.6%
1,308,5420.0%0.61%
-4.7%
Q3 2016$18,123,000
+81.9%
1,308,542
+29.7%
0.64%
+62.1%
Q2 2016$9,964,000
-41.6%
1,008,5420.0%0.39%
-42.0%
Q1 2016$17,054,000
-15.7%
1,008,542
+11.0%
0.68%
+18.9%
Q4 2015$20,224,000
-5.6%
908,5420.0%0.57%
-16.2%
Q3 2015$21,433,000908,5420.68%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2018
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$27,840,84218.82%
Ikarian Capital, LLC 1,891,147$11,781,8462.84%
Altium Capital Management LP 620,000$3,862,6001.96%
Ikarian Capital, LLC 1,296,900$8,079,6871.95%
Parkman Healthcare Partners LLC 822,784$5,125,9441.36%
Deep Track Capital, LP 4,000,000$24,920,0001.05%
Monaco Asset Management SAM 470,100$2,928,7230.88%
BRAIDWELL LP 3,393,405$21,140,9130.71%
Telemetry Investments, L.L.C. 71,000$4420.70%
Rhenman & Partners Asset Management AB 900,000$5,607,0000.58%
View complete list of ESPERION THERAPEUTICS INC NE shareholders